Article
The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment.
British journal of haematology - 1 Oct 1999
Rawstron A C, Rollinson S J, Richards S, Short M A, English A, Morgan G J, Hale G, Hillmen P
Abstract excerpt
Paroxysmal nocturnal haemoglobinuria (PNH) cells are deficient in glycosylphosphatidylinositol (GPI) linked antigens due to a somatic mutation of the PIG-A gene in a haemopoietic stem cell. It appears that a PNH clone reaches detectable proportions only when there is selection in its favour. GPI-deficient T lymphocytes have been identified in patients treated with CAMPATH-1H, a monoclonal antibody against the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
